January 2026
1. ROHNER S, Schnepper R, Meienberg A, Bopp K, et al
   Protocol of the digital long COVID study: A single-center, registry-based, feasibility and clinical evaluation study to investigate a 12-week digital intervention program for people affected by post-COVID-19 condition.
   PLoS One. 2026;21:e0340385.
   

   >> Share

   
   
2. ZHAO X, Yang Y, Liu Z, Sun R, et al
   Identifying chemicals associated with irritable bowel syndrome by integrating a transcriptome-wide association study with chemical-gene-interaction analysis.
   PLoS One. 2026;21:e0340666.
   

   >> Share

   
   
3. WONNEMANN M, Lipowicz B, Duysburgh C, Rotsaert C, et al
   Repeated dosing of myrrh, chamomile extract, and coffee charcoal reveals potential health-beneficial effects in patients with irritable bowel syndrome in the M-SHIME simulator.
   PLoS One. 2026;21:e0348791.
   

   >> Share

   
   
4. FEI Y, Gao MY, Qiao N, Hu J, et al
   Bioinformatic identification of CD8+ T cell activation mediated by key genes in fecal microbiota transplantation for irritable bowel syndrome.
   PLoS One. 2026;21:e0351574.
   

   >> Share

   
   
5. WILEMAN V, Czuber-Dochan W, Moss-Morris R, Dibley L, et al
   Supporting patients using a digital self-management intervention for symptoms of fatigue, pain, and urgency/incontinence in Inflammatory Bowel Disease: a mixed methods process evaluation of trial facilitators.
   PLoS One. 2026;21:e0350560.
   

   >> Share

   
   
6. ZHANG K, Mou F, Liu J, Wang J, et al
   Dysregulated glucocorticoid-responsive immune genes in peripheral blood mononuclear cells as a shared molecular signature of autism spectrum disorder and irritable bowel syndrome.
   PLoS One. 2026;21:e0353181.
   

   >> Share

   
   
7. HE X, Wang D, Yang B, Yan H, et al
   HIF-1alpha inhibits the TLR4/NF-kappaB signaling pathway and modulates intestinal flora in diarrhea-predominant irritable bowel syndrome.
   PLoS One. 2026;21:e0355467.
   

   >> Share

   
   January 2025
8. AKHLAQ S, Kazmi N, Kazmi SMH, Atiq M, et al
   Somatization symptomology and its association with stress in patients with irritable bowel syndrome.
   PLoS One. 2025;20:e0312506.
   

   >> Share

   
   
9. TATTAN M, Rosmalen J, Hanssen D
   Factors associated with receiving a Functional Disorder diagnostic label: A systematic review.
   PLoS One. 2025;20:e0317236.
   

   >> Share

   
   
10. ZHOU J, Lamichhane N, Xu Z, Wang J, et al
    The effect of acupuncture on quality of life in patients with irritable bowel syndrome: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0314678.
    

    >> Share

    
    
11. EKMAN L, Tufvesson H, Englund E, Dahlin LB, et al
    Symptoms and objective signs of peripheral sensory neuropathy in POTS and correlations to gastrointestinal symptoms.
    PLoS One. 2025;20:e0327549.
    

    >> Share

    
    
12. 
    Editorial Note: Somatization symptomology and its association with stress in patients with irritable bowel syndrome.
    PLoS One. 2025;20:e0331058.
    

    >> Share

    
    January 2024
13. LEE KS, Song IS, Kim ES, Kim J, et al
    Machine learning analysis with population data for the associations of preterm birth with temporomandibular disorder and gastrointestinal diseases.
    PLoS One. 2024;19:e0296329.
    

    >> Share

    
    
14. JORGENSEN T, Jacobsen RK, Saebye D, Petersen MW, et al
    Lipid metabolism and functional somatic disorders in the general population. The DanFunD study.
    PLoS One. 2024;19:e0296799.
    

    >> Share

    
    
15. LLUANSI A, Lliros M, Carreras-Torres R, Bahi A, et al
    Impact of bread diet on intestinal dysbiosis and irritable bowel syndrome symptoms in quiescent ulcerative colitis: A pilot study.
    PLoS One. 2024;19:e0297836.
    

    >> Share

    
    
16. SUN G, Jiang Y
    Major depressive disorder and irritable bowel syndrome risk: A Mendelian randomization study.
    PLoS One. 2024;19:e0300251.
    

    >> Share

    
    
17. DAI X, Liang M, Dai Y, Ding S, et al
    Causality of genetically determined blood metabolites on irritable bowel syndrome: A Mendelian randomization study.
    PLoS One. 2024;19:e0298963.
    

    >> Share

    
    
18. GUO Y, Lu Q, Yang XJ, He Y, et al
    Efficacy of Shu-yi-ning-chang decoction on IBS-D: Modulating Nr4a3 pathway to reduce visceral hypersensitivity.
    PLoS One. 2024;19:e0299376.
    

    >> Share

    
    
19. SCHOVSBO SU, Karhus LL, Bjerregaard AA, Petersen MW, et al
    Fluctuation of functional somatic disorders in a population-based cohort. The DanFunD study.
    PLoS One. 2024;19:e0312031.
    

    >> Share

    
    
20. KONIG J, Roca Rubio MF, Forsgard RA, Rode J, et al
    The effects of a 6-week intervention with Limosilactobacillus reuteri ATCC PTA 6475 alone and in combination with L. reuteri DSM 17938 on gut barrier function, immune markers, and symptoms in patients with IBS-D-An exploratory RCT.
    PLoS One. 2024;19:e0312464.
    

    >> Share

    
    January 2023
21. KHEMNU N, Serichantalergs O, Ruekit S, Lertsethtakarn P, et al
    Description of novel capsule biosynthesis loci of Campylobacter jejuni clinical isolates from South and South-East Asia.
    PLoS One. 2023;18:e0280583.
    

    >> Share

    
    
22. SCHALLER A, Vanderzande S, Peace C
    Deducing genotypes for loci of interest from SNP array data via haplotype sharing, demonstrated for apple and cherry.
    PLoS One. 2023;18:e0272888.
    

    >> Share

    
    
23. RAO STRB, Turek I, Irving HR
    Phylogenetic analyses of 5-hydroxytryptamine 3 (5-HT3) receptors in Metazoa.
    PLoS One. 2023;18:e0281507.
    

    >> Share

    
    
24. SCHORLING E, Lick S, Steinberg P, Bruggemann DA, et al
    Health care utilizations and costs of Campylobacter enteritis in Germany: A claims data analysis.
    PLoS One. 2023;18:e0283865.
    

    >> Share

    
    
25. CREED F
    Psychiatric disorders comorbid with general medical illnesses and functional somatic disorders: The Lifelines cohort study.
    PLoS One. 2023;18:e0286410.
    

    >> Share

    
    
26. WANG Y, Ke W, Gan J, Zhu H, et al
    MicroRNA-29b-3p promotes intestinal permeability in IBS-D via targeting TRAF3 to regulate the NF-kappaB-MLCK signaling pathway.
    PLoS One. 2023;18:e0287597.
    

    >> Share

    
    
27. TRAN TTT, Luu MN, Tran LL, Nguyen D, et al
    Association of mental health conditions and functional gastrointestinal disorders among Vietnamese new-entry medical students.
    PLoS One. 2023;18:e0289123.
    

    >> Share

    
    
28. MADRIGAL-VALENCIA TL, Saavedra-Montanez M, Perez-Torres A, Hernandez J, et al
    First identification and characterization of ovine gammaherpesvirus type 2 in horses and artiodactyla from an outbreak of malignant catarrhal fever in Mexico.
    PLoS One. 2023;18:e0290309.
    

    >> Share

    
    
29. GU Y, You Y, Guo G, Xie F, et al
    Effect of Prolong-life-with-nine-turn-method (Yan Nian Jiu Zhuan) Qigong on fatigue and gastrointestinal function in patients with chronic fatigue syndrome: Study protocol for a randomized controlled trial.
    PLoS One. 2023;18:e0287287.
    

    >> Share

    
    
30. TIAN J, Li T, Zhao J, Li D, et al
    Efficacy of different courses of acupuncture for diarrhea irritable bowel syndrome: A protocol for systematic review and meta-analysis.
    PLoS One. 2023;18:e0295077.
    

    >> Share

    
    January 2022
31. PAGAN-BUSIGO JE, Lopez-Carrasquillo J, Appleyard CB, Torres-Reveron A, et al
    Beyond depression and anxiety; a systematic review about the role of corticotropin-releasing hormone antagonists in diseases of the pelvic and abdominal organs.
    PLoS One. 2022;17:e0264909.
    

    >> Share

    
    
32. IVASHKIN VT, Kudryavtseva AV, Krasnov GS, Poluektov YM, et al
    Efficacy and safety of a food supplement with standardized menthol, limonene, and gingerol content in patients with irritable bowel syndrome: A double-blind, randomized, placebo-controlled trial.
    PLoS One. 2022;17:e0263880.
    

    >> Share

    
    
33. OZAKA S, Sonoda A, Ariki S, Minata M, et al
    Saireito, a Japanese herbal medicine, alleviates leaky gut associated with antibiotic-induced dysbiosis in mice.
    PLoS One. 2022;17:e0269698.
    

    >> Share

    
    
34. ABID S, Rehman H, Awan S, Artani A, et al
    Epidemiology of functional gastrointestinal disorders using ROME III adult questionnaire, a population based cross sectional study in Karachi-Pakistan.
    PLoS One. 2022;17:e0268403.
    

    >> Share

    
    
35. LIU J, Peng R, Tan Q, Li B, et al
    Proteomic analysis of rat colonic mucosa following acupuncture treatment for irritable bowel syndrome with diarrhea.
    PLoS One. 2022;17:e0273853.
    

    >> Share

    
    
36. GROZIC A, Coker K, Dussik CM, Sabir MS, et al
    Identification of putative transcriptomic biomarkers in irritable bowel syndrome (IBS): Differential gene expression and regulation of TPH1 and SERT by vitamin D.
    PLoS One. 2022;17:e0275683.
    

    >> Share

    
    
37. HINSE M, Thronicke A, Berghofer A, Matthes H, et al
    New multimodal intervention to reduce irritable bowel syndrome (IBS) severity symptoms-Pilot study with a 12 month follow-up.
    PLoS One. 2022;17:e0277880.
    

    >> Share

    
    
38. NAKATA R, Tanaka F, Sugawara N, Kojima Y, et al
    Analysis of autonomic function during natural defecation in patients with irritable bowel syndrome using real-time recording with a wearable device.
    PLoS One. 2022;17:e0278922.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share